Research Compound Profile

Semaglutide: Research Profile (November 2026)

Semaglutide is an acylated analogue of human GLP-1(7–37) engineered for DPP-4 resistance and albumin binding, giving it a half-life of about one week.

For laboratory research and educational purposes only. This profile summarizes published preclinical and analytical literature and is not medical advice or dosing guidance.

Research-Grade Semaglutide

Supplied as Semaglutide 5mg with a batch-specific HPLC and mass spectrometry COA — verify any batch.

Further Reading

Other Compound Profiles